4/18
09:11 am
femy
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives [Yahoo! Finance]
Low
Report
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives [Yahoo! Finance]
4/18
08:30 am
femy
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
Low
Report
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
4/1
09:01 am
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
4/1
08:08 am
femy
Femasys Inc. (NASDAQ: FEMY) had its price target raised by analysts at HC Wainwright from $10.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its price target raised by analysts at HC Wainwright from $10.00 to $12.00. They now have a "buy" rating on the stock.
3/31
09:38 am
femy
Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
High
Report
Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
3/28
04:19 pm
femy
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update [Yahoo! Finance]
High
Report
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update [Yahoo! Finance]
3/28
04:05 pm
femy
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
Medium
Report
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
3/21
01:42 pm
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Low
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
3/21
09:00 am
femy
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
Medium
Report
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
3/21
08:34 am
femy
Femasys Inc. (NASDAQ: FEMY) had its price target raised by analysts at Jonestrading from $7.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its price target raised by analysts at Jonestrading from $7.00 to $10.00. They now have a "buy" rating on the stock.
3/21
08:06 am
femy
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/20
08:33 am
femy
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility [Yahoo! Finance]
Medium
Report
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility [Yahoo! Finance]
3/20
08:15 am
femy
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
High
Report
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
3/13
09:22 am
femy
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 [Yahoo! Finance]
Medium
Report
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 [Yahoo! Finance]
3/13
09:00 am
femy
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
Medium
Report
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
3/6
09:20 am
femy
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution [Yahoo! Finance]
Medium
Report
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution [Yahoo! Finance]
3/6
09:00 am
femy
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
High
Report
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
2/28
09:07 am
femy
Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF [Yahoo! Finance]
Neutral
Report
Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF [Yahoo! Finance]
2/28
09:00 am
femy
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
Medium
Report
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
2/6
08:46 am
femy
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer [Yahoo! Finance]
High
Report
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer [Yahoo! Finance]
2/6
08:30 am
femy
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
High
Report
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
1/26
08:10 am
femy
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women [Yahoo! Finance]
Medium
Report
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women [Yahoo! Finance]
1/26
08:00 am
femy
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Medium
Report
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
1/23
08:37 am
femy
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology [Yahoo! Finance]
Low
Report
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology [Yahoo! Finance]
1/23
08:30 am
femy
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
Medium
Report
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology